Accelerating the Future of Health
COVID-19 responses from the health ecosystem
Responding to COVID-19 is an enormous challenge for companies of all sizes and in all sectors, not least life sciences. The pandemic is affecting the pharmaceutical ecosystem and highlighting the importance of health technology economically, politically, and socially.
COVID-19: Shaping the future regulation of emergency medical equipment supply
The COVID-19 pandemic has disrupted everyone’s daily lives and touched every industry across the world. While many countries had influenza and other pandemic preparedness plans in place prior to COVID-19, no one was fully prepared for the speed and indiscriminate spread of the disease.
How can virtual health help expand capacity in the wake of an anticipated COVID-19 surge?
When faced with a health crisis like Covid-19, social distancing can take some of the strain off healthcare providers at the front lines. But when that’s not enough, innovations like virtual healthcare can help increase capacity, reduce the rate of infection, and treat non-urgent cases.
Forging the links across the value chain
The biopharmaceutical sector is facing digital disruption from multiple sources, the chief among them being artificial intelligence (AI) and cloud. Deloitte predicts that in 2019/2020, all industries will accelerate their use of cloud-based AI software and services, including biopharma companies.